J.M. Minke

1.3k total citations
30 papers, 895 citations indexed

About

J.M. Minke is a scholar working on Epidemiology, Immunology and Agronomy and Crop Science. According to data from OpenAlex, J.M. Minke has authored 30 papers receiving a total of 895 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Epidemiology, 10 papers in Immunology and 9 papers in Agronomy and Crop Science. Recurrent topics in J.M. Minke's work include Influenza Virus Research Studies (8 papers), Virus-based gene therapy research (8 papers) and Animal Disease Management and Epidemiology (7 papers). J.M. Minke is often cited by papers focused on Influenza Virus Research Studies (8 papers), Virus-based gene therapy research (8 papers) and Animal Disease Management and Epidemiology (7 papers). J.M. Minke collaborates with scholars based in France, United Kingdom and Netherlands. J.M. Minke's co-authors include Janet M. Daly, Jean-Christophe Audonnet, Pierre-Michel Guigal, Julia H. Kydd, D. Hannant, Jean-Christophe Audonnet, Romain Paillot, Richard A. Bowen, L. Siger and V. Juillard and has published in prestigious journals such as Journal of General Virology, Vaccine and Alimentary Pharmacology & Therapeutics.

In The Last Decade

J.M. Minke

30 papers receiving 873 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
J.M. Minke France 18 399 354 247 211 165 30 895
Barry J. Rodwell Australia 10 589 1.5× 414 1.2× 221 0.9× 131 0.6× 103 0.6× 10 851
Oskar‐Rüger Kaaden Germany 15 320 0.8× 301 0.9× 100 0.4× 189 0.9× 125 0.8× 24 716
Hansi Dean United States 18 380 1.0× 317 0.9× 121 0.5× 202 1.0× 256 1.6× 46 942
Helena Lage Ferreira Brazil 19 658 1.6× 397 1.1× 224 0.9× 186 0.9× 138 0.8× 86 1.1k
Esmeralda Minguijón Spain 20 554 1.4× 277 0.8× 297 1.2× 46 0.2× 185 1.1× 38 1.2k
Josh Slater United Kingdom 20 615 1.5× 136 0.4× 191 0.8× 281 1.3× 178 1.1× 44 1.1k
Hsien-Jue Chu United States 16 303 0.8× 281 0.8× 192 0.8× 61 0.3× 126 0.8× 22 660
P.-P. Pastoret Belgium 24 624 1.6× 359 1.0× 337 1.4× 83 0.4× 243 1.5× 74 1.3k
Yoshio Fukunaga Japan 18 280 0.7× 551 1.6× 446 1.8× 168 0.8× 120 0.7× 72 1.2k
L. Rønsholt Denmark 22 360 0.9× 459 1.3× 528 2.1× 82 0.4× 141 0.9× 34 1.2k

Countries citing papers authored by J.M. Minke

Since Specialization
Citations

This map shows the geographic impact of J.M. Minke's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J.M. Minke with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J.M. Minke more than expected).

Fields of papers citing papers by J.M. Minke

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J.M. Minke. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J.M. Minke. The network helps show where J.M. Minke may publish in the future.

Co-authorship network of co-authors of J.M. Minke

This figure shows the co-authorship network connecting the top 25 collaborators of J.M. Minke. A scholar is included among the top collaborators of J.M. Minke based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J.M. Minke. J.M. Minke is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Crafford, J. E., et al.. (2012). An African horse sickness virus serotype 4 recombinant canarypox virus vaccine elicits specific cell-mediated immune responses in horses. Veterinary Immunology and Immunopathology. 149(1-2). 76–85. 21 indexed citations
2.
El‐Hage, Charles, et al.. (2012). Accelerated vaccination schedule provides protective levels of antibody and complete herd immunity to equine influenza. Equine Veterinary Journal. 45(2). 235–239. 14 indexed citations
3.
4.
Minke, J.M., L. Siger, Lionel Cupillard, et al.. (2011). Protection provided by a recombinant ALVAC®-WNV vaccine expressing the prM/E genes of a lineage 1 strain of WNV against a virulent challenge with a lineage 2 strain. Vaccine. 29(28). 4608–4612. 38 indexed citations
5.
6.
Bublot, Michel, Kemal Karaca, J.M. Minke, et al.. (2008). Current influenza vaccines for poultry and other animal species.. Alimentary Pharmacology & Therapeutics. 52(5). 117–136. 6 indexed citations
7.
Minke, J.M., Stephanie A Richard, C. Andréoni, et al.. (2008). A West Nile virus (WNV) recombinant canarypox virus vaccine elicits WNV-specific neutralizing antibodies and cell-mediated immune responses in the horse. Veterinary Immunology and Immunopathology. 123(3-4). 230–239. 72 indexed citations
8.
Minke, J.M., Florence Cliquet, Marine Wasniewski, et al.. (2008). Comparison of antibody responses after vaccination with two inactivated rabies vaccines. Veterinary Microbiology. 133(3). 283–286. 47 indexed citations
9.
Minke, J.M., et al.. (2007). Effective Priming of Foals Born to Immune Dams against Influenza by a Canarypox-Vectored Recombinant Influenza H3N8 Vaccine. Journal of Comparative Pathology. 137. S76–S80. 25 indexed citations
10.
Paillot, Romain, Julia H. Kydd, Shona MacRae, et al.. (2007). New assays to measure equine influenza virus-specific Type 1 immunity in horses. Vaccine. 25(42). 7385–7398. 22 indexed citations
11.
Minke, J.M., et al.. (2006). Use of DNA and recombinant canarypox viral (ALVAC) vectors for equine herpes virus vaccination. Veterinary Immunology and Immunopathology. 111(1-2). 47–57. 38 indexed citations
12.
Paillot, Romain, Julia H. Kydd, D. Hannant, et al.. (2006). Antibody and IFN-γ responses induced by a recombinant canarypox vaccine and challenge infection with equine influenza virus. Veterinary Immunology and Immunopathology. 112(3-4). 225–233. 57 indexed citations
13.
Karaca, Kemal, Richard A. Bowen, L. Siger, et al.. (2005). Recombinant canarypox vectored West Nile virus (WNV) vaccine protects dogs and cats against a mosquito WNV challenge. Vaccine. 23(29). 3808–3813. 42 indexed citations
14.
Paillot, Romain, Janet M. Daly, V. Juillard, et al.. (2005). Equine interferon gamma synthesis in lymphocytes after in vivo infection and in vitro stimulation with EHV-1. Vaccine. 23(36). 4541–4551. 58 indexed citations
15.
Minke, J.M., L. Siger, Kemal Karaca, et al.. (2004). Recombinant canarypoxvirus vaccine carrying the prM/E genes of West Nile virus protects horses against a West Nile virus-mosquito challenge. PubMed. 221–230. 94 indexed citations
16.
Maanen, C. van, et al.. (2003). Diagnostic methods applied to analysis of an outbreak of equine influenza in a riding school in which vaccine failure occurred. Veterinary Microbiology. 93(4). 291–306. 14 indexed citations
17.
Minke, J.M., E. J. Hensen, & W. Misdorp. (1995). Uterine carcinomas in mother cats after intrafetal inoculation of allogeneic tumor cells (K248 C and P). Veterinary Immunology and Immunopathology. 46(3-4). 361–366. 1 indexed citations
18.
Iványi, Dagmar, et al.. (1993). Cytokeratins as markers of initial stages of squamous metaplasia in feline mammary carcinomas. American Journal of Veterinary Research. 54(7). 1095–1102. 6 indexed citations
19.
Iványi, Dagmar, et al.. (1992). Patterns of expression of feline cytokeratins in healthy epithelia and mammary carcinoma cells. American Journal of Veterinary Research. 53(3). 304–314. 26 indexed citations
20.
Minke, J.M., Ed Schuuring, J. Boonstra, et al.. (1991). Isolation of two distinct epithelial cell lines from a single feline mammary carcinoma with different tumorigenic potential in nude mice and expressing different levels of epidermal growth factor receptors.. PubMed. 51(15). 4028–37. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Barry J. Rodwell Breakdown of academic impact, for papers by Oskar‐Rüger Kaaden Breakdown of academic impact, for papers by Hansi Dean Breakdown of academic impact, for papers by Helena Lage Ferreira Breakdown of academic impact, for papers by Esmeralda Minguijón Breakdown of academic impact, for papers by Josh Slater Breakdown of academic impact, for papers by Hsien-Jue Chu Breakdown of academic impact, for papers by P.-P. Pastoret Breakdown of academic impact, for papers by Yoshio Fukunaga Breakdown of academic impact, for papers by L. Rønsholt
Rankless by CCL
2026